Haloperidol Drug Level

Label Mnemonic:	HALO
Epic code:	LAB3264
Downtime form:	Doctor/Provider Orders - Pathology Core and Specialty Care Nursery

Commercial Mailout Laboratory
6240-8 RCP
356-8593

Specimen(s):

Serum

Specimen Instructions:

Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration.

Collection Medium:

Red top tube 5 mL (Clot Activator)

Minimum:

Preferred Minimum: 1 mL serum
Absolute Minimum: .5 mL serum

Rejection Criteria:

Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution).

Delivery Instructions:

Submit specimen to laboratory as soon as possible after collection.

Turn Around Time:

1-7 days upon receipt at reference laboratory.

Reference Range:

Therapeutic Range: 1.0–10.0 ng/mL

Toxic: Greater than or equal to 15.0 ng/mL

Interpretive Data:

The therapeutic range is based on serum pre-dose (trough) draw at steady-state concentration. Adverse effects to haloperidol therapy may include drowsiness, blurred vision, tardive dyskinesia, tachycardia, hypotension, and muscular rigidity.

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA-certified laboratory and is intended for clinical purposes.

Methodology:

Quantitative Liquid Chromatography-Tandem Mass Spectrometry

CPT Code:

80173